首页 › 基金 › Opaleye Management Inc. › RYTM
Opaleye Management Inc. 对 RYTM 的持仓历史
RHYTHM PHARMACEUTICALS INC · 医疗保健
Opaleye Management Inc. 在 Q2 2026 的 13F 申报中披露持有 RYTM(RHYTHM PHARMACEUTICALS INC)122,500 股,市值约 US$13.6M,约占其申报组合的 1.23%,在其申报持仓中市值排名第 23 位。 Opaleye Management Inc. 最近 12 个申报季度中有 12 个季度披露了 RYTM 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Opaleye Management Inc. 对 RYTM 的持仓演变
Opaleye Management Inc. 于 Q3 2023 首次披露 RYTM 持仓:653,000 股(约 US$15.0M)。 该持仓在 Q3 2025 达到峰值 461,700 股,市值约 US$46.6M。 在 12 次申报中,Opaleye Management Inc. 0 次增持、8 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 122,500 股、市值约 US$13.6M。 持仓曾出现大幅变动:Q4 2025 减持约 29% (随后一个季度股价下跌 19%)、Q1 2026 减持约 63% (随后一个季度股价上涨 28%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 653.00K | $14.97M | 新进 |
| Q4 2023 | 610.00K | $28.04M | 减持 |
| Q1 2024 | 515.00K | $22.31M | 减持 |
| Q2 2024 | 515.00K | $21.15M | 持有 |
| Q3 2024 | 500.00K | $26.20M | 减持 |
| Q4 2024 | 500.00K | $27.99M | 持有 |
| Q1 2025 | 490.00K | $25.96M | 减持 |
| Q2 2025 | 475.00K | $30.02M | 减持 |
| Q3 2025 | 461.70K | $46.63M | 减持 |
| Q4 2025 | 330.00K | $35.32M | 减持 |
| Q1 2026 | 123.00K | $35.32M | 减持 |
| Q2 2026 | 122.50K | $13.60M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RYTM 与 13F 数据
RYTM(RHYTHM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 RYTM,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RYTM 的基金
- RA CAPITAL MANAGEMENT, L.P. 6.67M 股 · $740.22M · Q2 2026
- BAKER BROS. ADVISORS LP 5.60M 股 · $622.27M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.59M 股 · $287.16M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.21M 股 · $245.22M · Q2 2026
- Polar Capital Holdings Plc 1.66M 股 · $184.71M · Q2 2026
- Checkpoint Capital L.P. 1.19M 股 · $131.68M · Q2 2026
- Siren, L.L.C. 1.14M 股 · $126.16M · Q2 2026
- Rock Springs Capital Management LP 692.60K 股 · $76.90M · Q2 2026
- Integral Health Asset Management, LLC 550.00K 股 · $61.07M · Q2 2026
- Sofinnova Investments, Inc. 408.03K 股 · $45.30M · Q2 2026
- BRAIDWELL LP 381.13K 股 · $42.32M · Q2 2026
更多关于 Opaleye Management Inc.
常见问题
How long has Opaleye Management Inc. held RYTM?
Opaleye Management Inc. has disclosed RYTM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Opaleye Management Inc.'s current position in RYTM?
As of Q2 2026, Opaleye Management Inc. holds 122.50K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $13.60M, representing 1.23% of its reported portfolio and ranking #23.
Has Opaleye Management Inc. been buying or selling RYTM?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in RYTM. The position peaked in Q3 2025 at 461.70K shares.
Which other funds hold RYTM?
Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.